Covid-19 Workshop
Topics
Date(s)
10 Nov 2020
Program Language
English
Meeting type
Virtual
CME Credits
1
Organizer
Virology Education_logo
Educational Partner
Erasmus Medical Center

COVID-19 Online Educational Program - 10 November

Overview
COVID-19 Update for Healthcare Professionals

WHAT YOU NOW NEED TO KNOW

The emergence of SARS-CoV2 has provoked unprecedented public healthcare measures globally, confronting not only ID doctors but everyone working in public health. These healthcare providers are faced with uncertainties on how to efficiently and effectively detect, treat, and monitor infected patients. With data and guidelines still evolving, there is a continuous stream of new information on the virus and the disease that it causes. Healthcare providers fighting the pandemic on multiple frontlines are in urgent need of a medical education resource that will expertly review and distil data into a concise and clear message to help them make informed treatment decisions for their patients.

This is part of a series of online interactive meetings on COVID-19. This livestream took place on Tuesday, 10 November 2020.

Program Directors
Program
- 20:00
20:00
Welcome, Program Agenda & Objectives
Anton Pozniak
Anton Pozniak MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
20:05
Update on COVID-19 Epidemiology and Management Strategies
Yonatan Grad
Yonatan Grad MD, PhD
Harvard T.H. Chan School of Public Health, United States
20:25
Shelter From the Storm? Reassessing the Role of Tocilizumab in COVID-19 Pneumonia
Jonathan Parr
Jonathan Parr, MD, MPH
University of North Carolina School of Medicine, United States
20:45
Remdesivir — What do the Clinical Trials Tell Us?
Daniel Kuritzkes
Daniel Kuritzkes MD
Brigham and Women's Hospital / Harvard Medical School, United States
21:05
Roundtable discussion & Update on Recent Vaccine and Monoclonal Antibody Developments
Anton Pozniak
Anton Pozniak MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
Support
Support

Gilead Sciences, MSD, and Janssen have provided part funding for this Independent Medical Education program.

Gilead, MSD, and Janssen have had no input into selection of speakers or the content of the materials and presentations.

Endorsers